HOME >> MEDICINE >> NEWS
Cancer gene therapy news backgrounder: New ideas fuel next generation gene therapy research

ctor taken up by the bone marrow cells.

Roth, now chairman of the Department of Thoracic and Cardiovascular Surgery, had more success. He found that an abnormal or missing p53 gene in lung tumors could be successfully replaced in experimental animals. The p53 gene, which normally acts as a brake against uncontrolled cell growth, is missing or mutated in about half of human cancers, and dysfunctional in most of the rest.

Based on the animal experiments, the first lung cancer patient underwent gene therapy in early 1995, and in mid-1996, Roth and his group published a study describing the first reported successful replacement of a defective p53 tumor suppressor gene. M. D. Anderson licensed the finding to the biotech company, Introgen, which Roth helped create and for which he is now a paid consultant. "It all started here at M. D. Anderson with the concept, vector development, preclinical trials and the first phase of testing," says Roth. "This agent has clinical benefit, and because of its novelty and lack of interest by major pharmaceutical companies, the only way to make it available to patients was to start a biotech company. But it has been a long road."

Introgen conducted phase II studies on the therapy, which it calls Advexin, and found that lung tumors shrank in over half of the patients who used it when combined with radiation therapy. Moreover, there have been unexpected long-term survivors, and these findings have sent the company to the FDA for fast track approval, which is currently being considered. More than 20 completed or ongoing trials are testing Advexin in such solid tumors as lung, head and neck, breast and ovarian. Some of these trials are now ongoing at M. D. Anderson, as well as at other cancer centers around the world.

But the drug has limitations. It uses an adenovirus, the microbe that causes the common cold, as a "vector" - a sort of taxicab - that carries genetic material directly into cancer cells. The vir
'"/>

Contact: Nancy Jensen
nwjensen@mdanderson.org
713-792-0655
University of Texas M. D. Anderson Cancer Center
5-May-2004


Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Cancer in patients with hepatitis C
2. Olson family donates $1 million to Arizona Cancer Center
3. Cancer vaccines: A two-pronged attack?
4. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
5. ESMO and Imedex announce partnership for the World Congress on Gastrointestinal Cancer
6. UT Southwestern Moncrief Cancer Center is first in Texas to treat patients with TomoTherapy
7. Cancer researchers seek to predict tumor growth
8. UGA professor receives $3 million grant from National Cancer Institute for breast cancer research
9. Cancer patients in Europe unite with doctors
10. Fox Chase Cancer Center researchers identify novel target for detecting ovarian cancer in blood
11. Cancer burden seen even many years after diagnosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2020)... ... 2020 , ... BenefitScape, a leader in ACA compliance reporting ... in connection with new legislation called the New Jersey Health Insurance Market Preservation ... obtain health insurance, have a valid exemption, or pay a penalty called the ...
(Date:2/26/2020)... ... February 26, 2020 , ... ... 1pm EST with featured speaker Cristian Ionescu-Zanetti, PhD, Chief Technology Officer, Fluxion Biosciences ... IsoFlux system is a bench-top solution for high-sensitivity circulating tumor cell (CTC) enrichment ...
(Date:2/23/2020)... ... February 22, 2020 , ... Although many people ... Queendom.com reveals that some people who dismiss compliments struggle with their ... from 9,568 who took the Emotional Intelligence Test, Queendom researchers focused ...
(Date:2/21/2020)... ... February 21, 2020 , ... Used for years as a ... traction as a viable replacement for invasive cosmetic surgery, such as breast augmentation. ... remain the market leader for the expected robust growth of autologous fat grafting ...
(Date:2/20/2020)... (PRWEB) , ... February 20, 2020 , ... R3 Medical ... Las Vegas Nevada. Providers will learn how to perform injections for all large and ... not easy to learn from online videos. The best opportunity is to perform injections ...
Breaking Medicine News(10 mins):
(Date:2/28/2020)... ... February 27, 2020 , ... ... life sciences in the Salesforce® ecosystem, announced today that its Unified, End-to-End Document ... CSF Certified status demonstrates that the zPaper Document and Data Automation Platform for ...
(Date:2/28/2020)... , ... February 27, 2020 , ... Returning for a ... will be speaking in a special “In Conversation With…” on Friday, May 29th, at ... this prolific entrepreneur, investor and business leader. CWCBExpo New York, taking place May 28–30, ...
(Date:2/28/2020)... , ... February 27, 2020 , ... This Women’s History ... with VA. , “For the Department of Veterans Affairs, Women’s History Month means ... of the role we play in the remaining chapters of their story,” said VA ...
Breaking Medicine Technology:
Cached News: